Targeting the gut microbiome in the management of sepsis-associated encephalopathy
Copyright © 2022 Barlow, Ponnaluri, Barlow and Roth..
Brain injury resulting from sepsis, or sepsis-associated encephalopathy (SAE), occurs due to impaired end-organ perfusion, dysregulated inflammation affecting the central nervous system (CNS), blood-brain barrier (BBB) disruption, mitochondrial dysfunction, oxidative stress, accumulation of toxic neuropeptides and impaired toxin clearance secondary to sepsis-induced hepatic and renal dysfunction. The gut microbiome becomes pathologically altered in sepsis, which likely contributes to the pathogenesis of SAE. Herein, we review the literature detailing dysregulation of microbiota-gut-brain axis (MGBA) in SAE and highlight potential therapeutic strategies to modulate the gut microbiome to mitigate sepsis-induced brain injury.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
---|---|
Enthalten in: |
Frontiers in neurology - 13(2022) vom: 01., Seite 999035 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Barlow, Brooke [VerfasserIn] |
---|
Links: |
---|
Themen: |
Fecal microbiota transplantation |
---|
Anmerkungen: |
Date Revised 19.10.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3389/fneur.2022.999035 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM347627242 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM347627242 | ||
003 | DE-627 | ||
005 | 20231226034258.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3389/fneur.2022.999035 |2 doi | |
028 | 5 | 2 | |a pubmed24n1158.xml |
035 | |a (DE-627)NLM347627242 | ||
035 | |a (NLM)36247756 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Barlow, Brooke |e verfasserin |4 aut | |
245 | 1 | 0 | |a Targeting the gut microbiome in the management of sepsis-associated encephalopathy |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 19.10.2022 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Copyright © 2022 Barlow, Ponnaluri, Barlow and Roth. | ||
520 | |a Brain injury resulting from sepsis, or sepsis-associated encephalopathy (SAE), occurs due to impaired end-organ perfusion, dysregulated inflammation affecting the central nervous system (CNS), blood-brain barrier (BBB) disruption, mitochondrial dysfunction, oxidative stress, accumulation of toxic neuropeptides and impaired toxin clearance secondary to sepsis-induced hepatic and renal dysfunction. The gut microbiome becomes pathologically altered in sepsis, which likely contributes to the pathogenesis of SAE. Herein, we review the literature detailing dysregulation of microbiota-gut-brain axis (MGBA) in SAE and highlight potential therapeutic strategies to modulate the gut microbiome to mitigate sepsis-induced brain injury | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a T cell | |
650 | 4 | |a Vagus nerve (VN) stimulation | |
650 | 4 | |a fecal microbiota transplantation | |
650 | 4 | |a gut microbiome | |
650 | 4 | |a probiotics | |
650 | 4 | |a sepsis | |
650 | 4 | |a sepsis-associated encephalopathy | |
700 | 1 | |a Ponnaluri, Sameer |e verfasserin |4 aut | |
700 | 1 | |a Barlow, Ashley |e verfasserin |4 aut | |
700 | 1 | |a Roth, William |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Frontiers in neurology |d 2010 |g 13(2022) vom: 01., Seite 999035 |w (DE-627)NLM204500133 |x 1664-2295 |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:2022 |g day:01 |g pages:999035 |
856 | 4 | 0 | |u http://dx.doi.org/10.3389/fneur.2022.999035 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 13 |j 2022 |b 01 |h 999035 |